chrX:47582408:> Detail (hg38)
Information
Genome
Assembly | Position |
---|---|
hg19 | chrX:47,441,807-47,446,188 |
hg38 | chrX:47,582,408-47,586,789 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.007 | squamous cell carcinoma | NA | BeFree,LHGDN | Detail | |
<0.001 | Cardiomyopathy, Dilated | NA | BeFree | Detail | |
<0.001 | Cardiovascular Diseases | However, until now only a handful number of genetic variants were reported to be... | BeFree | 25169573 | Detail |
0.003 | carotid stenosis | NA | BeFree,LHGDN | Detail | |
<0.001 | celiac disease | NA | BeFree | Detail | |
<0.001 | CNS disorder | NA | BeFree | Detail | |
<0.001 | Central Nervous System Infection | NA | BeFree | Detail | |
0.083 | intracranial aneurysm | NA | BeFree,LHGDN,RGD | Detail | |
<0.001 | Malignant tumor of cervix | NA | BeFree | Detail | |
0.080 | cholestasis | NA | RGD | Detail | |
0.002 | chorioamnionitis | NA | GAD | Detail | |
<0.001 | choriocarcinoma | NA | BeFree | Detail | |
0.006 | ulcerative colitis | NA | BeFree,LHGDN | Detail | |
0.003 | Colonic Neoplasms | NA | BeFree,LHGDN | Detail | |
0.005 | colorectal carcinoma | TIMP-1 expression in human colorectal cancer is associated with SMAD3 gene expre... | BeFree | 25532000 | Detail |
0.012 | Colorectal Neoplasms | NA | BeFree,LHGDN | Detail | |
0.003 | Febrile Convulsions | NA | BeFree,LHGDN | Detail | |
<0.001 | Coronary Arteriosclerosis | NA | BeFree | Detail | |
0.005 | Coronary heart disease | NA | BeFree,GAD | Detail | |
0.006 | Crohn Disease | NA | BeFree,GAD,LHGDN | Detail | |
0.003 | Dermatitis, Atopic | NA | LHGDN | Detail | |
<0.001 | Stasis dermatitis | NA | BeFree | Detail | |
<0.001 | scleroderma | NA | BeFree | Detail | |
0.001 | Diabetes | However, until now only a handful number of genetic variants were reported to be... | BeFree | 25169573 | Detail |
0.001 | diabetes mellitus | However, until now only a handful number of genetic variants were reported to be... | BeFree | 25169573 | Detail |
0.200 | Diabetes Mellitus, Experimental | NA | CTD_human,RGD | Detail | |
0.001 | Diabetes Mellitus, Insulin-Dependent | NA | BeFree | Detail | |
0.121 | Diabetes Mellitus, Non-Insulin-Dependent | The presence of type 2 diabetes associated with 3.2-fold increased PAI-1 express... | BeFree,CTD_human | 25496999 | Detail |
0.002 | Diabetic Angiopathies | NA | GAD | Detail | |
0.001 | Diabetic Nephropathy | NA | BeFree | Detail | |
<0.001 | diabetic retinopathy | NA | BeFree | Detail | |
0.003 | Muscular Dystrophy, Duchenne | NA | BeFree,LHGDN | Detail | |
0.003 | duodenal ulcer | NA | BeFree,GAD | Detail | |
0.003 | Edema | NA | LHGDN | Detail | |
<0.001 | encephalitis | NA | BeFree | Detail | |
0.002 | Endometrial Neoplasms | NA | GAD | Detail | |
0.003 | endometriosis | NA | BeFree,LHGDN | Detail | |
0.002 | Fetal Membranes, Premature Rupture | NA | GAD | Detail | |
<0.001 | breast fibrocystic disease | NA | BeFree | Detail | |
0.005 | Fibrosis | NA | LHGDN | Detail | |
0.001 | glioblastoma | NA | BeFree | Detail | |
0.003 | Glioma | NA | BeFree | Detail | |
0.003 | glomerulonephritis | NA | BeFree,LHGDN | Detail | |
0.120 | IgA glomerulonephritis | NA | CTD_human | Detail | |
<0.001 | goiter | NA | BeFree | Detail | |
0.002 | Graft Occlusion, Vascular | NA | GAD | Detail | |
0.200 | Heart Diseases | NA | BeFree,CTD_human,RGD | Detail | |
0.081 | Heart failure | NA | BeFree,RGD | Detail | |
<0.001 | congestive heart failure | NA | BeFree | Detail | |
0.120 | heart valve disease | NA | CTD_human | Detail | |
<0.001 | hemochromatosis | NA | BeFree | Detail | |
0.003 | Hemorrhage | NA | LHGDN | Detail | |
0.120 | Hepatolenticular Degeneration | NA | CTD_human | Detail | |
<0.001 | Hepatosplenomegaly | NA | BeFree | Detail | |
<0.001 | HIV Infections | NA | BeFree | Detail | |
0.003 | Hodgkin Disease | NA | BeFree,LHGDN | Detail | |
0.003 | Hypercholesterolemia, Familial | NA | BeFree,LHGDN | Detail | |
0.083 | Hypertensive disease | The presence of type 2 diabetes associated with 3.2-fold increased PAI-1 express... | BeFree,LHGDN,RGD | 25496999 | Detail |
0.003 | Hypertension, Portal | NA | LHGDN | Detail | |
0.123 | Inflammation | NA | CTD_human,LHGDN | Detail | |
0.004 | Inflammatory Bowel Diseases | NA | BeFree,LHGDN | Detail | |
<0.001 | ischemia | NA | BeFree | Detail | |
<0.001 | Keloid | NA | BeFree | Detail | |
0.001 | keratoconus | NA | BeFree | Detail | |
0.003 | Kidney Diseases | NA | BeFree,LHGDN | Detail | |
0.001 | Kidney Failure, Chronic | NA | BeFree | Detail | |
0.002 | Premature Obstetric Labor | NA | GAD | Detail | |
<0.001 | Fibroid Tumor | EPO mRNA expression was detected in 108 of 114, or 95%, of the leiomyomas. | BeFree | 25724399 | Detail |
<0.001 | leukemia | NA | BeFree | Detail | |
0.001 | Acute Erythroblastic Leukemia | NA | BeFree | Detail | |
<0.001 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
<0.001 | Leukemia, Lymphocytic, Acute, L1 | NA | BeFree | Detail | |
<0.001 | Leukemia, Myelocytic, Acute | NA | BeFree | Detail | |
0.003 | myeloid leukemia | NA | LHGDN | Detail | |
<0.001 | Myeloid Leukemia, Chronic | NA | BeFree | Detail | |
0.003 | liver cirrhosis | NA | BeFree,GAD | Detail | |
0.120 | Liver Cirrhosis, Alcoholic | NA | CTD_human | Detail | |
0.200 | Liver Cirrhosis, Experimental | NA | BeFree,CTD_human,RGD | Detail | |
<0.001 | Liver diseases | NA | BeFree | Detail | |
0.001 | Liver neoplasms | NA | BeFree | Detail | |
0.006 | Chronic Obstructive Airway Disease | A significantly higher TIMP1 level in blood serum was observed in the COPD + can... | BeFree,GAD,LHGDN | 25292126 | Detail |
0.006 | Chronic Obstructive Airway Disease | Effect of Liuweibuqi capsule, a Chinese patent medicine, on the JAK1/STAT3 pathw... | BeFree,GAD,LHGDN | 25842729 | Detail |
<0.001 | Lupus Erythematosus, Systemic | NA | BeFree | Detail | |
0.007 | lymphoma | NA | BeFree,LHGDN | Detail | |
0.003 | Lymphoma, Non-Hodgkin | NA | BeFree,GAD | Detail | |
<0.001 | Lymphoproliferative Disorders | NA | BeFree | Detail | |
<0.001 | Mycetoma | NA | BeFree | Detail | |
0.003 | Malignant neoplasm of stomach | Real-Time PCR and western blot showed increasing of HIF-1α in mRNA and protein l... | BeFree | 24927122 | Detail |
<0.001 | Marfan syndrome | NA | BeFree | Detail | |
0.005 | melanoma | NA | BeFree,LHGDN | Detail | |
0.003 | meningioma | NA | BeFree,LHGDN | Detail | |
0.003 | viral meningitis | NA | BeFree,LHGDN | Detail | |
<0.001 | Metabolic Diseases | NA | BeFree | Detail | |
0.002 | Metaplasia | NA | GAD | Detail | |
<0.001 | Mixed Salivary Gland Tumor | NA | BeFree | Detail | |
<0.001 | Moyamoya disease | NA | BeFree | Detail | |
0.003 | Mucocutaneous Lymph Node Syndrome | NA | LHGDN | Detail | |
0.004 | multiple myeloma | NA | BeFree,LHGDN | Detail | |
0.005 | multiple sclerosis | NA | BeFree,LHGDN | Detail | |
<0.001 | muscular dystrophy | NA | BeFree | Detail | |
0.006 | myocardial infarction | Our findings indicate that overexpression of MMP-9 and TIMPs in blood mononuclea... | BeFree,GAD,LHGDN | 25153995 | Detail |
<0.001 | Nasal Polyps | NA | BeFree | Detail | |
<0.001 | Necrotizing Scleritis | NA | BeFree | Detail | |
0.123 | Neoplasm Invasiveness | NA | CTD_human,LHGDN | Detail | |
0.022 | Neoplasm Metastasis | Our findings identify hRAB37 as a novel metastasis suppressor Rab that functions... | BeFree,LHGDN | 25183545 | Detail |
0.022 | Neoplasm Metastasis | In summary, this study presents novel functions of TIMP-1 in promoting cancer me... | BeFree,LHGDN | 25578494 | Detail |
<0.001 | nephroblastoma | NA | BeFree | Detail | |
<0.001 | nervous system disorder | NA | BeFree | Detail | |
0.003 | Neuromuscular Diseases | NA | LHGDN | Detail | |
<0.001 | obesity | NA | BeFree | Detail | |
0.121 | oral submucous fibrosis | NA | BeFree,CTD_human | Detail | |
0.001 | Degenerative polyarthritis | NA | BeFree | Detail | |
<0.001 | osteosarcoma | NA | BeFree | Detail | |
0.001 | ovarian carcinoma | NA | BeFree | Detail | |
<0.001 | Pancreatic Neoplasm | NA | BeFree | Detail | |
0.001 | periodontitis | NA | BeFree | Detail | |
<0.001 | pituitary adenoma | NA | BeFree | Detail | |
<0.001 | Pituitary Diseases | NA | BeFree | Detail | |
<0.001 | Pleural effusion disorder | NA | BeFree | Detail | |
<0.001 | pneumonia | NA | BeFree | Detail | |
0.003 | polycystic ovary syndrome | NA | LHGDN | Detail | |
0.002 | polycythemia | NA | BeFree | Detail | |
<0.001 | polycythemia vera | NA | BeFree | Detail | |
0.002 | pre-eclampsia | NA | GAD | Detail | |
<0.001 | progeria | NA | BeFree | Detail | |
0.003 | Prostatic Neoplasms | NA | LHGDN | Detail | |
0.120 | pulmonary fibrosis | NA | BeFree,CTD_human | Detail | |
0.005 | pyelonephritis | NA | LHGDN | Detail | |
<0.001 | Refractive Errors | NA | BeFree | Detail | |
<0.001 | kidney failure | NA | BeFree | Detail | |
<0.001 | Respiratory Syncytial Virus Infections | NA | BeFree | Detail | |
<0.001 | retinal degeneration | NA | BeFree | Detail | |
<0.001 | Retinal Diseases | However, until now only a handful number of genetic variants were reported to be... | BeFree | 25169573 | Detail |
0.011 | systemic scleroderma | In contrast, TIMP-1 levels were higher in SSc but DHLA had minimal effect. | BeFree,GAD,LHGDN | 25123250 | Detail |
0.011 | systemic scleroderma | miR-29a repressed TAB1-mediated TIMP-1 production in dermal fibroblasts, demonst... | BeFree,GAD,LHGDN | 25549087 | Detail |
0.003 | Sclerosis | NA | LHGDN | Detail | |
0.003 | Skin Neoplasms | NA | LHGDN | Detail | |
0.003 | ankylosing spondylitis | NA | BeFree,GAD | Detail | |
0.003 | Stomach Neoplasms | NA | LHGDN | Detail | |
0.080 | gastric ulcer | NA | RGD | Detail | |
0.080 | Cerebrovascular accident | Our results provide evidence for a positive effect of simvastatin on the MMP met... | BeFree,RGD | 25476155 | Detail |
0.003 | subacute sclerosing panencephalitis | NA | LHGDN | Detail | |
<0.001 | Subarachnoid Hemorrhage | NA | BeFree | Detail | |
0.004 | Thyroid Neoplasm | NA | BeFree,LHGDN | Detail | |
<0.001 | tuberculosis | NA | BeFree | Detail | |
<0.001 | Tuberculosis, Meningeal | NA | BeFree | Detail | |
<0.001 | Uterine Fibroids | EPO mRNA expression was detected in 108 of 114, or 95%, of the leiomyomas. | BeFree | 25724399 | Detail |
0.120 | Varicosity | NA | BeFree,CTD_human | Detail | |
0.200 | Vascular Diseases | NA | CTD_human,RGD | Detail | |
<0.001 | Virus Diseases | NA | BeFree | Detail | |
<0.001 | Werner syndrome | NA | BeFree | Detail | |
0.001 | Wiskott-Aldrich syndrome | NA | BeFree | Detail | |
<0.001 | epidermolysis bullosa acquisita | NA | BeFree | Detail | |
<0.001 | Hallopeau-Siemens Disease | NA | BeFree | Detail | |
0.005 | Helicobacter Infections | NA | BeFree,GAD | Detail | |
<0.001 | Ichthyosis, X-Linked | NA | BeFree | Detail | |
<0.001 | B-Cell Lymphomas | NA | BeFree | Detail | |
<0.001 | High Grade Lymphoma (neoplasm) | NA | BeFree | Detail | |
<0.001 | Lymphoma, Large-Cell, Follicular | NA | BeFree | Detail | |
<0.001 | severe combined immunodeficiency | NA | BeFree | Detail | |
0.003 | Meningitis, Bacterial | NA | LHGDN | Detail | |
<0.001 | Depressive Symptoms | Our findings indicate that overexpression of MMP-9 and TIMPs in blood mononuclea... | BeFree | 25153995 | Detail |
<0.001 | benign neoplasm | NA | BeFree | Detail | |
0.003 | Epstein-Barr Virus Infections | NA | LHGDN | Detail | |
<0.001 | Left Ventricular Hypertrophy | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of lung | NA | BeFree | Detail | |
0.002 | Premature Birth | NA | GAD | Detail | |
<0.001 | renal fibrosis | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of lung (disorder) | Down-regulation of TIMP-1 inhibits cell migration, invasion, and metastatic colo... | BeFree | 25578494 | Detail |
<0.001 | esophageal carcinoma | NA | BeFree | Detail | |
<0.001 | Idiopathic pulmonary hypertension | NA | BeFree | Detail | |
<0.001 | Familial erythrocytosis | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of gallbladder | NA | BeFree | Detail | |
0.001 | Secondary malignant neoplasm of lung | NA | BeFree | Detail | |
<0.001 | Corneal pannus | NA | BeFree | Detail | |
0.081 | Intervertebral Disc Degeneration | NA | BeFree,RGD | Detail | |
<0.001 | Cicatrix, Hypertrophic | NA | BeFree | Detail | |
0.011 | Aortic Aneurysm, Abdominal | NA | BeFree,GAD,LHGDN | Detail | |
0.002 | Tumor Progression | Only recently, TIMP-1 has been revealed as a signalling molecule that can regula... | BeFree | 25263437 | Detail |
0.002 | Tumor Progression | Tissue inhibitor of metalloproteinases-1 is a glycoprotein, which regulates meta... | BeFree | 25608838 | Detail |
<0.001 | Microinvasive tumor | NA | BeFree | Detail | |
<0.001 | Anaplastic carcinoma | NA | BeFree | Detail | |
<0.001 | Undifferentiated carcinoma | NA | BeFree | Detail | |
<0.001 | Diabetic Foot | This work studied the expression of selected MMP and tissue inhibitor of metallo... | BeFree | 25168880 | Detail |
0.004 | Ki-1+ Anaplastic Large Cell Lymphoma | NA | BeFree,LHGDN | Detail | |
<0.001 | Adenomatous Polyps | NA | BeFree | Detail | |
0.002 | pancreatic carcinoma | NA | BeFree | Detail | |
<0.001 | Colitis, Collagenous | NA | BeFree | Detail | |
0.001 | Papillary thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | bone destruction | NA | BeFree | Detail | |
0.005 | Fibrosis, Liver | Hepatocyte growth factor (HGF) gene transfer inhibits liver fibrosis by regulati... | BeFree | 25380300 | Detail |
0.005 | Fibrosis, Liver | Serum from patients with liver fibrosis was examined for adiponectin and tissue ... | BeFree | 25575598 | Detail |
<0.001 | Interstitial fibrosis | NA | BeFree | Detail | |
0.001 | Malignant neoplasm of lung | This new pro-tumourigenic signalling function of TIMP-1 may explain why elevated... | BeFree | 25263437 | Detail |
0.001 | Malignant neoplasm of lung | We compared the frequency of single nucleotide polymorphisms in genes coding for... | BeFree | 25292126 | Detail |
0.001 | Malignant neoplasm of lung | Tissue inhibitor metalloproteinase-1 (TIMP-1) is clinically associated with a po... | BeFree | 25578494 | Detail |
<0.001 | age related macular degeneration | NA | BeFree | Detail | |
0.080 | Hyperoxia | NA | RGD | Detail | |
0.003 | Sepsis | NA | LHGDN | Detail | |
<0.001 | Childhood asthma | NA | BeFree | Detail | |
<0.001 | Cerebral Vasospasm | NA | BeFree | Detail | |
<0.001 | Ichthyosis linearis circumflexa | Interestingly, the highest level of EPO/% retic ratio as indicated for EPO non-r... | BeFree | 25477265 | Detail |
<0.001 | Chronic Periodontitis | NA | BeFree | Detail | |
<0.001 | Intestinal metaplasia of gastric mucosa | NA | BeFree | Detail | |
<0.001 | Ocular albinism, type II | NA | BeFree | Detail | |
<0.001 | Endometrioma | NA | BeFree | Detail | |
<0.001 | Impaired glucose tolerance | NA | BeFree | Detail | |
<0.001 | Tuberculosis, Central Nervous System | NA | BeFree | Detail | |
<0.001 | Carcinoma breast stage IV | NA | BeFree | Detail | |
<0.001 | Metastatic melanoma | NA | BeFree | Detail | |
<0.001 | Invasive lobular breast carcinoma | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of esophagus | The aim of this study was to investigate the role of RUNX3 in esophageal squamou... | BeFree | 25428380 | Detail |
<0.001 | Adenocarcinoma Of Esophagus | NA | BeFree | Detail | |
<0.001 | laryngeal squamous cell carcinoma | NA | BeFree | Detail | |
<0.001 | Vascular Neoplasms | NA | BeFree | Detail | |
<0.001 | cervix carcinoma | NA | BeFree | Detail | |
0.004 | Restenosis | NA | BeFree,GAD | Detail | |
<0.001 | Chronic ulcer | NA | BeFree | Detail | |
<0.001 | Superficial ulcer | NA | BeFree | Detail | |
<0.001 | anaplastic astrocytoma | NA | BeFree | Detail | |
<0.001 | pilocytic astrocytoma | NA | BeFree | Detail | |
<0.001 | X-linked retinitis pigmentosa | NA | BeFree | Detail | |
<0.001 | Glaucoma, Primary Open Angle | NA | BeFree | Detail | |
<0.001 | Stable angina | NA | BeFree | Detail | |
<0.001 | Chronic liver disease | NA | BeFree | Detail | |
<0.001 | sialuria | NA | BeFree | Detail | |
<0.001 | Benign neoplasm of breast | NA | BeFree | Detail | |
0.001 | Malignant neoplasm of pancreas | NA | BeFree | Detail | |
<0.001 | Isolated aortic stenosis | NA | BeFree | Detail | |
<0.001 | Ischemic cardiomyopathy | NA | BeFree | Detail | |
0.002 | Malignant neoplasm of prostate | Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction... | BeFree | 25623427 | Detail |
<0.001 | Hereditary gingival fibromatosis | NA | BeFree | Detail | |
<0.001 | Lipodermatosclerosis | NA | BeFree | Detail | |
<0.001 | endometrial carcinoma | NA | BeFree | Detail | |
0.003 | Secondary malignant neoplasm of liver | NA | BeFree | Detail | |
0.003 | dementia | NA | LHGDN | Detail | |
<0.001 | Necrotizing Enterocolitis | NA | BeFree | Detail | |
<0.001 | Fibrosis of bile duct | NA | BeFree | Detail | |
<0.001 | acute pyelonephritis | NA | BeFree | Detail | |
<0.001 | Metabolic syndrome X | In MetS; the T-allele associated with 5.5 fold increase in event rate (p<0.0001)... | BeFree | 25191702 | Detail |
0.003 | Hepatitis B, Chronic | NA | LHGDN | Detail | |
0.003 | Hepatitis C, Chronic | NA | BeFree,GAD | Detail | |
<0.001 | Thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | Malignant glioma | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of mouth | NA | BeFree | Detail | |
<0.001 | Osteosarcoma of bone | NA | BeFree | Detail | |
<0.001 | Carcinogenesis | NA | BeFree | Detail | |
<0.001 | hyperhomocysteinemia | NA | BeFree | Detail | |
<0.001 | Leukemogenesis | NA | BeFree | Detail | |
0.003 | prostate carcinoma | Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction... | BeFree | 25623427 | Detail |
<0.001 | Epithelial ovarian cancer | NA | BeFree | Detail | |
<0.001 | invasive cancer | NA | BeFree | Detail | |
0.010 | breast carcinoma | Our findings highlight TIMP-3 induction as a key epigenetic event modulated by G... | BeFree | 24481780 | Detail |
0.010 | breast carcinoma | Angiogenic cytokines which are known to regulate tumorigenicity and angiogenesis... | BeFree | 24941346 | Detail |
0.010 | breast carcinoma | Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of met... | BeFree | 25721604 | Detail |
<0.001 | polycythemia vera | As compared to their JAK2 V617F negative counterparts, the JAK2 V617F positive p... | BeFree | 18616871 | Detail |
0.002 | Carcinoma of lung | This new pro-tumourigenic signalling function of TIMP-1 may explain why elevated... | BeFree | 25263437 | Detail |
0.002 | Carcinoma of lung | We compared the frequency of single nucleotide polymorphisms in genes coding for... | BeFree | 25292126 | Detail |
0.002 | Carcinoma of lung | Tissue inhibitor metalloproteinase-1 (TIMP-1) is clinically associated with a po... | BeFree | 25578494 | Detail |
<0.001 | Malignant neoplasm of gastrointestinal tract | NA | BeFree | Detail | |
<0.001 | CNS metastases | NA | BeFree | Detail | |
0.003 | Secondary malignant neoplasm of lymph node | NA | BeFree | Detail | |
<0.001 | Community acquired pneumonia | NA | BeFree | Detail | |
0.003 | colon carcinoma | NA | BeFree | Detail | |
0.004 | stomach carcinoma | Real-Time PCR and western blot showed increasing of HIF-1α in mRNA and protein l... | BeFree | 24927122 | Detail |
<0.001 | Carcinoma of bladder | NA | BeFree | Detail | |
<0.001 | Brain Tumor, Primary | NA | BeFree | Detail | |
<0.001 | Helicobacter pylori infection | NA | BeFree | Detail | |
<0.001 | Adenoviral infections | NA | BeFree | Detail | |
0.005 | Pregnancy associated hypertension | NA | LHGDN | Detail | |
<0.001 | Post MI | NA | BeFree | Detail | |
<0.001 | Borderline ovarian tumour | NA | BeFree | Detail | |
<0.001 | Muscle fibrosis | NA | BeFree | Detail | |
<0.001 | Advanced cancer | NA | BeFree | Detail | |
<0.001 | Asthma chronic | NA | BeFree | Detail | |
<0.001 | Cardiomyopathies | NA | BeFree | Detail | |
<0.001 | Stromal Neoplasm | NA | BeFree | Detail | |
0.003 | ovarian neoplasm | NA | BeFree,LHGDN | Detail | |
<0.001 | Metastatic Prostate Carcinoma | NA | BeFree | Detail | |
<0.001 | precancerous lesions | NA | BeFree | Detail | |
<0.001 | Acute coronary syndrome | NA | BeFree | Detail | |
<0.001 | Primary infection NOS | NA | BeFree | Detail | |
<0.001 | Colorectal cancer metastatic | TIMP-1 and CEA as biomarkers in third-line treatment with irinotecan and cetuxim... | BeFree | 25608838 | Detail |
<0.001 | Arthritis, Collagen-Induced | NA | BeFree | Detail | |
<0.001 | Sialic Acid Storage Disease, Finnish Type (disorder) | NA | BeFree | Detail | |
0.003 | Malignant neoplasm of ovary | NA | BeFree,GAD | Detail | |
<0.001 | Renal anemia | NA | BeFree | Detail | |
<0.001 | Mammary Carcinoma, Human | NA | BeFree | Detail | |
0.002 | Stenosis | NA | GAD | Detail | |
<0.001 | Acral pseudolymphomatous angiokeratoma of children (APACHE) | NA | BeFree | Detail | |
<0.001 | Adenoma of large intestine | NA | BeFree | Detail | |
<0.001 | chronic venous insufficiency | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma of large intestine | The RPL35, RPS23 and TIMP1 genes were found to be overexpressed in both early an... | BeFree | 25107436 | Detail |
<0.001 | autoimmune lymphoproliferative syndrome | NA | BeFree | Detail | |
<0.001 | Epithelioma | NA | BeFree | Detail | |
<0.001 | Cardiomyopathy, Familial Idiopathic | NA | BeFree | Detail | |
<0.001 | Diabetic foot ulcer | This work studied the expression of selected MMP and tissue inhibitor of metallo... | BeFree | 25168880 | Detail |
0.012 | Mammary Neoplasms | NA | BeFree,LHGDN | Detail | |
<0.001 | Breast Cancer Model | NA | BeFree | Detail | |
<0.001 | Tumor Angiogenesis | MMPs and TIMPs play important roles in tumor angiogenesis and invasion. | BeFree | 25533828 | Detail |
0.004 | colorectal cancer | TIMP-1 expression in human colorectal cancer is associated with SMAD3 gene expre... | BeFree | 25532000 | Detail |
<0.001 | Cirrhosis | NA | BeFree | Detail | |
<0.001 | Non-Neoplastic Disorder | NA | BeFree | Detail | |
<0.001 | Aggressive periodontitis, generalized | Matrix metalloproteinase (MMP)-8 and tissue inhibitor of MMP-1 (TIMP-1) gene pol... | BeFree | 24283658 | Detail |
0.120 | Female Urogenital Diseases | NA | CTD_human | Detail | |
<0.001 | Meningioma, benign, no ICD-O subtype | NA | BeFree | Detail | |
<0.001 | Idiopathic Pulmonary Fibrosis | NA | BeFree | Detail | |
<0.001 | THROMBOCYTOPENIA 1 (disorder) | NA | BeFree | Detail | |
<0.001 | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A | NA | BeFree | Detail | |
<0.001 | Dyssegmental dysplasia | NA | BeFree | Detail | |
<0.001 | uterine corpus cancer | NA | BeFree | Detail | |
<0.001 | coronary artery disease | NA | BeFree | Detail | |
<0.001 | Parvovirus B19 (disease) | NA | BeFree | Detail | |
<0.001 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | BeFree | Detail | |
<0.001 | Postmenopausal endometrium | NA | BeFree | Detail | |
0.014 | liver carcinoma | NA | BeFree,LHGDN | Detail | |
<0.001 | Destructive Arthritis | NA | BeFree | Detail | |
<0.001 | Mycetoma of foot | NA | BeFree | Detail | |
<0.001 | RETINITIS PIGMENTOSA 2 (disorder) | NA | BeFree | Detail | |
0.002 | Infection of amniotic sac and membranes, unspecified, unspecified trimester, not applicable or unspecified | NA | GAD | Detail | |
<0.001 | Moyamoya disease 1 | NA | BeFree | Detail | |
<0.001 | Pulmonary arterial hypertension | NA | BeFree | Detail | |
<0.001 | Valvular disease | NA | BeFree | Detail | |
0.003 | Juvenile arthritis | NA | LHGDN | Detail | |
0.003 | Infection | NA | LHGDN | Detail | |
<0.001 | Pulmonary hypertension, primary, 1, with hereditary hemorrhagic telangiectasia | NA | BeFree | Detail | |
<0.001 | Portal fibrosis | NA | BeFree | Detail | |
0.002 | adenocarcinoma | NA | BeFree | Detail | |
<0.001 | adenoma | NA | BeFree | Detail | |
0.005 | Alzheimer's disease | NA | GAD,LHGDN | Detail | |
<0.001 | amyloidosis | NA | BeFree | Detail | |
0.003 | amyotrophic lateral sclerosis | NA | BeFree,LHGDN | Detail | |
0.001 | anemia | NA | BeFree | Detail | |
0.003 | Aneurysm | NA | BeFree,GAD | Detail | |
<0.001 | Angina, Unstable | NA | BeFree | Detail | |
0.001 | aortic aneurysm | NA | BeFree | Detail | |
0.120 | aortic valve insufficiency | NA | CTD_human | Detail | |
<0.001 | aortic valve stenosis | NA | BeFree | Detail | |
<0.001 | arteriosclerosis | NA | BeFree | Detail | |
<0.001 | Arteriovenous fistula | NA | BeFree | Detail | |
0.003 | arthritis | NA | BeFree,GAD | Detail | |
<0.001 | Arthritis, Psoriatic | NA | BeFree | Detail | |
0.004 | rheumatoid arthritis | NA | BeFree,GAD | Detail | |
0.006 | asthma | NA | BeFree,GAD,LHGDN | Detail | |
0.001 | Astrocytoma | NA | BeFree | Detail | |
0.004 | atherosclerosis | NA | BeFree,LHGDN | Detail | |
<0.001 | Autoimmune Diseases | NA | BeFree | Detail | |
<0.001 | Melanoma, B16 | NA | BeFree | Detail | |
0.003 | biliary atresia | NA | BeFree,LHGDN | Detail | |
<0.001 | Malignant neoplasm of urinary bladder | NA | BeFree | Detail | |
<0.001 | Brain Neoplasms | NA | BeFree | Detail | |
0.009 | Malignant neoplasm of breast | Our findings highlight TIMP-3 induction as a key epigenetic event modulated by G... | BeFree | 24481780 | Detail |
0.009 | Malignant neoplasm of breast | Angiogenic cytokines which are known to regulate tumorigenicity and angiogenesis... | BeFree | 24941346 | Detail |
0.009 | Malignant neoplasm of breast | Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of met... | BeFree | 25721604 | Detail |
0.003 | bronchiolitis obliterans | NA | LHGDN | Detail | |
0.005 | bronchopulmonary dysplasia | NA | LHGDN | Detail | |
<0.001 | Burkitt lymphoma | NA | BeFree | Detail | |
0.120 | calcinosis | NA | CTD_human | Detail | |
0.003 | Malignant tumor of colon | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of endometrium | NA | BeFree | Detail | |
0.002 | Rectal Carcinoma | NA | GAD | Detail | |
<0.001 | Malignant neoplasm of thyroid | NA | BeFree | Detail | |
0.002 | Non-small cell lung carcinoma | NA | BeFree | Detail | |
0.002 | renal cell carcinoma | NA | BeFree | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
However, until now only a handful number of genetic variants were reported to be associated with eit... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
TIMP-1 expression in human colorectal cancer is associated with SMAD3 gene expression levels: a pilo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
However, until now only a handful number of genetic variants were reported to be associated with eit... | DisGeNET | Detail |
However, until now only a handful number of genetic variants were reported to be associated with eit... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The presence of type 2 diabetes associated with 3.2-fold increased PAI-1 expression (adjusted p=0.03... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The presence of type 2 diabetes associated with 3.2-fold increased PAI-1 expression (adjusted p=0.03... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
EPO mRNA expression was detected in 108 of 114, or 95%, of the leiomyomas. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
A significantly higher TIMP1 level in blood serum was observed in the COPD + cancer group than in th... | DisGeNET | Detail |
Effect of Liuweibuqi capsule, a Chinese patent medicine, on the JAK1/STAT3 pathway and MMP9/TIMP1 in... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Real-Time PCR and western blot showed increasing of HIF-1α in mRNA and protein levels as well as TIM... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our findings indicate that overexpression of MMP-9 and TIMPs in blood mononuclear cells and elevated... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our findings identify hRAB37 as a novel metastasis suppressor Rab that functions through the TIMP1-M... | DisGeNET | Detail |
In summary, this study presents novel functions of TIMP-1 in promoting cancer metastasis and suggest... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
However, until now only a handful number of genetic variants were reported to be associated with eit... | DisGeNET | Detail |
In contrast, TIMP-1 levels were higher in SSc but DHLA had minimal effect. | DisGeNET | Detail |
miR-29a repressed TAB1-mediated TIMP-1 production in dermal fibroblasts, demonstrating that miR-29a ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our results provide evidence for a positive effect of simvastatin on the MMP metabolism in human BME... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
EPO mRNA expression was detected in 108 of 114, or 95%, of the leiomyomas. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our findings indicate that overexpression of MMP-9 and TIMPs in blood mononuclear cells and elevated... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Down-regulation of TIMP-1 inhibits cell migration, invasion, and metastatic colonization in lung ade... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Only recently, TIMP-1 has been revealed as a signalling molecule that can regulate cancer progressio... | DisGeNET | Detail |
Tissue inhibitor of metalloproteinases-1 is a glycoprotein, which regulates metalloproteinases and m... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This work studied the expression of selected MMP and tissue inhibitor of metalloproteinases (TIMP) g... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Hepatocyte growth factor (HGF) gene transfer inhibits liver fibrosis by regulating aberrant cellular... | DisGeNET | Detail |
Serum from patients with liver fibrosis was examined for adiponectin and tissue inhibitor of metallo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
This new pro-tumourigenic signalling function of TIMP-1 may explain why elevated TIMP-1 levels in lu... | DisGeNET | Detail |
We compared the frequency of single nucleotide polymorphisms in genes coding for matrix proteinases ... | DisGeNET | Detail |
Tissue inhibitor metalloproteinase-1 (TIMP-1) is clinically associated with a poor prognosis for var... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Interestingly, the highest level of EPO/% retic ratio as indicated for EPO non-responder was detecte... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The aim of this study was to investigate the role of RUNX3 in esophageal squamous cell carcinoma (ES... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating mac... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In MetS; the T-allele associated with 5.5 fold increase in event rate (p<0.0001), increased with num... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating mac... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our findings highlight TIMP-3 induction as a key epigenetic event modulated by GTPs in restoring the... | DisGeNET | Detail |
Angiogenic cytokines which are known to regulate tumorigenicity and angiogenesis, such as GM-CSF, IG... | DisGeNET | Detail |
Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIM... | DisGeNET | Detail |
As compared to their JAK2 V617F negative counterparts, the JAK2 V617F positive patients had PV-like ... | DisGeNET | Detail |
This new pro-tumourigenic signalling function of TIMP-1 may explain why elevated TIMP-1 levels in lu... | DisGeNET | Detail |
We compared the frequency of single nucleotide polymorphisms in genes coding for matrix proteinases ... | DisGeNET | Detail |
Tissue inhibitor metalloproteinase-1 (TIMP-1) is clinically associated with a poor prognosis for var... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Real-Time PCR and western blot showed increasing of HIF-1α in mRNA and protein levels as well as TIM... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
TIMP-1 and CEA as biomarkers in third-line treatment with irinotecan and cetuximab for metastatic co... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The RPL35, RPS23 and TIMP1 genes were found to be overexpressed in both early and advanced stage col... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This work studied the expression of selected MMP and tissue inhibitor of metalloproteinases (TIMP) g... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
MMPs and TIMPs play important roles in tumor angiogenesis and invasion. | DisGeNET | Detail |
TIMP-1 expression in human colorectal cancer is associated with SMAD3 gene expression levels: a pilo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Matrix metalloproteinase (MMP)-8 and tissue inhibitor of MMP-1 (TIMP-1) gene polymorphisms in genera... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Our findings highlight TIMP-3 induction as a key epigenetic event modulated by GTPs in restoring the... | DisGeNET | Detail |
Angiogenic cytokines which are known to regulate tumorigenicity and angiogenesis, such as GM-CSF, IG... | DisGeNET | Detail |
Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIM... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs386626619 dbSNP
- Genome
- hg38
- Position
- chrX:47,582,408-47,586,789
- Variant Type
- snv
Genome browser